$99.01
4.19% yesterday
Nasdaq, Oct 30, 09:13 pm CET

Illumina Stock price

$99.01
+4.04 4.25% 1M
+21.41 27.59% 6M
-34.62 25.91% YTD
-48.65 32.95% 1Y
-123.93 55.59% 3Y
-186.17 65.28% 5Y
-40.59 29.07% 10Y
+91.43 1,205.36% 20Y
Nasdaq, Closing price Thu, Oct 30 2025
+3.98 4.19%

Key metrics

Basic
Market capitalization
$14.6b
Enterprise Value
$15.4b
Net debt
$836.0m
Cash
$1.2b
Shares outstanding
154.0m
Valuation (TTM | estimate)
P/E
11.9 | 20.6
P/S
3.4 | 3.4
EV/Sales
3.6 | 3.6
EV/FCF
15.0
P/B
6.5
Financial Health
Equity Ratio
37.7%
Return on Equity
-51.5%
ROCE
19.6%
ROIC
18.5%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$4.3b | $4.3b
EBITDA
$1.2b | $1.2b
EBIT
$905.0m | $961.9m
Net Income
$1.3b | $709.4m
Free Cash Flow
$1.0b
Growth (TTM | estimate)
Revenue
-3.3% | -0.6%
EBITDA
76.3% | 76.1%
EBIT
275.5% | 45.5%
Net Income
141.3% | 158.0%
Free Cash Flow
188.8%
Margin (TTM | estimate)
Gross
67.1%
EBITDA
27.6% | 26.9%
EBIT
21.1%
Net
29.4% | 16.3%
Free Cash Flow
24.1%
More
EPS
$8.0
FCF per Share
$6.7
Short interest
6.8%
Employees
9k
Rev per Employee
$490.0k
Show more

Is Illumina a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,029 stocks worldwide.

Illumina Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Illumina forecast:

13x Buy
45%
13x Hold
45%
3x Sell
10%

Analyst Opinions

29 Analysts have issued a Illumina forecast:

Buy
45%
Hold
45%
Sell
10%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,284 4,284
3% 3%
100%
- Direct Costs 1,410 1,410
16% 16%
33%
2,874 2,874
5% 5%
67%
- Selling and Administrative Expenses 977 977
19% 19%
23%
- Research and Development Expense 992 992
24% 24%
23%
1,183 1,183
76% 76%
28%
- Depreciation and Amortization 278 278
35% 35%
6%
EBIT (Operating Income) EBIT 905 905
276% 276%
21%
Net Profit 1,258 1,258
141% 141%
29%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
Seeking Alpha
about 2 hours ago
Illumina, Inc. ( ILMN ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Conor Noel McNamara - VP of Investor Relations Jacob Thaysen - CEO & Director Ankur Dhingra - Chief Financial Officer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Douglas Schenkel - Wolfe Research, LLC Vijay Kumar - Evercore ISI Institutional Equities, Research ...
Neutral
PRNewsWire
about 8 hours ago
Revenue of $1.08 billion for Q3 2025, flat compared to Q3 2024 on both a reported and constant currency basis GAAP operating margin of 21.0% and non-GAAP operating margin of 24.5% for Q3 2025 GAAP diluted EPS of $0.98 and non-GAAP diluted EPS of $1.34 for Q3 2025 Cash provided by operations of $284 million and free cash flow of $253 million for Q3 2025 Repurchased 1.2 million shares of our comm...
Positive
Seeking Alpha
9 days ago
Illumina is at a pivotal moment, balancing near-term challenges with innovations in multiomics, AI, and proteomics to redefine its growth trajectory. ILMN's planned SomaLogic acquisition and new AI-driven initiatives like BioInsight strengthen its multiomics strategy and expand high-margin revenue streams. Despite competition and risks from China and regulatory pressures, ILMN maintains strong ...
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 9,000
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today